[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:smooth-muscle-neoplasm":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Smooth Muscle Neoplasm",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06239272","NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:06.247899Z","2026-07-19T19:36:05.068230Z",[],[]]